Covid-19 Impact on Insulin Syringes Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Insulin Syringes, including the following market information:
Major competitors identified in this market include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories, Animas Corporation, F. Hoffmann-La Roche, BD, etc.
Based on the Region:
- Global Insulin Syringes Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Insulin Syringes Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Insulin Syringes Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Insulin Syringes Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories, Animas Corporation, F. Hoffmann-La Roche, BD, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- 3/10 cc syringe
- 1/2 cc syringe
- 1 cc syringe
- Others
- Hospital
- Homecare
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Insulin Syringes Industry
1.7 COVID-19 Impact: Insulin Syringes Market Trends
2 GLOBAL INSULIN SYRINGES QUARTERLY MARKET SIZE ANALYSIS
2.1 Insulin Syringes Business Impact Assessment - COVID-19
2.1.1 Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Insulin Syringes Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Insulin Syringes Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Insulin Syringes Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Insulin Syringes Factory Price by Manufacturers
3.3 Location of Key Manufacturers Insulin Syringes Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Insulin Syringes Market
3.5 Key Manufacturers Insulin Syringes Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INSULIN SYRINGES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 3/10 cc syringe
1.4.2 1/2 cc syringe
1.4.3 1 cc syringe
1.4.4 Others
4.2 By Type, Global Insulin Syringes Market Size, 2019-2021
4.2.1 By Type, Global Insulin Syringes Market Size by Type, 2020-2021
4.2.2 By Type, Global Insulin Syringes Price, 2020-2021
5 IMPACT OF COVID-19 ON INSULIN SYRINGES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Homecare
5.5.3 Others
5.2 By Application, Global Insulin Syringes Market Size, 2019-2021
5.2.1 By Application, Global Insulin Syringes Market Size by Application, 2019-2021
5.2.2 By Application, Global Insulin Syringes Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Business Overview
7.1.2 Novo Nordisk Insulin Syringes Quarterly Production and Revenue, 2020
7.1.3 Novo Nordisk Insulin Syringes Product Introduction
7.1.4 Novo Nordisk Response to COVID-19 and Related Developments
7.2 Sanofi
7.2.1 Sanofi Business Overview
7.2.2 Sanofi Insulin Syringes Quarterly Production and Revenue, 2020
7.2.3 Sanofi Insulin Syringes Product Introduction
7.2.4 Sanofi Response to COVID-19 and Related Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Business Overview
7.3.2 Eli Lilly and Company Insulin Syringes Quarterly Production and Revenue, 2020
7.3.3 Eli Lilly and Company Insulin Syringes Product Introduction
7.3.4 Eli Lilly and Company Response to COVID-19 and Related Developments
7.4 Biocon Ltd
7.4.1 Biocon Ltd Business Overview
7.4.2 Biocon Ltd Insulin Syringes Quarterly Production and Revenue, 2020
7.4.3 Biocon Ltd Insulin Syringes Product Introduction
7.4.4 Biocon Ltd Response to COVID-19 and Related Developments
7.5 Ypsomed AG
7.5.1 Ypsomed AG Business Overview
7.5.2 Ypsomed AG Insulin Syringes Quarterly Production and Revenue, 2020
7.5.3 Ypsomed AG Insulin Syringes Product Introduction
7.5.4 Ypsomed AG Response to COVID-19 and Related Developments
7.6 Wockhardt Ltd
7.6.1 Wockhardt Ltd Business Overview
7.6.2 Wockhardt Ltd Insulin Syringes Quarterly Production and Revenue, 2020
7.6.3 Wockhardt Ltd Insulin Syringes Product Introduction
7.6.4 Wockhardt Ltd Response to COVID-19 and Related Developments
7.7 Medtronic Plc
7.7.1 Medtronic Plc Business Overview
7.7.2 Medtronic Plc Insulin Syringes Quarterly Production and Revenue, 2020
7.7.3 Medtronic Plc Insulin Syringes Product Introduction
7.7.4 Medtronic Plc Response to COVID-19 and Related Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Business Overview
7.8.2 Abbott Laboratories Insulin Syringes Quarterly Production and Revenue, 2020
7.8.3 Abbott Laboratories Insulin Syringes Product Introduction
7.8.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.9 Animas Corporation
7.9.1 Animas Corporation Business Overview
7.9.2 Animas Corporation Insulin Syringes Quarterly Production and Revenue, 2020
7.9.3 Animas Corporation Insulin Syringes Product Introduction
7.9.4 Animas Corporation Response to COVID-19 and Related Developments
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Business Overview
7.10.2 F. Hoffmann-La Roche Insulin Syringes Quarterly Production and Revenue, 2020
7.10.3 F. Hoffmann-La Roche Insulin Syringes Product Introduction
7.10.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
7.11 BD
7.11.1 BD Business Overview
7.11.2 BD Insulin Syringes Quarterly Production and Revenue, 2020
7.11.3 BD Insulin Syringes Product Introduction
7.11.4 BD Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Insulin Syringes Supply Chain Analysis
8.1.1 Insulin Syringes Supply Chain Analysis
8.1.2 Covid-19 Impact on Insulin Syringes Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Insulin Syringes Distribution Channels
8.2.2 Covid-19 Impact on Insulin Syringes Distribution Channels
8.2.3 Insulin Syringes Distributors
8.3 Insulin Syringes Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Insulin Syringes Industry
1.7 COVID-19 Impact: Insulin Syringes Market Trends
2 GLOBAL INSULIN SYRINGES QUARTERLY MARKET SIZE ANALYSIS
2.1 Insulin Syringes Business Impact Assessment - COVID-19
2.1.1 Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Insulin Syringes Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Insulin Syringes Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Insulin Syringes Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Insulin Syringes Factory Price by Manufacturers
3.3 Location of Key Manufacturers Insulin Syringes Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Insulin Syringes Market
3.5 Key Manufacturers Insulin Syringes Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INSULIN SYRINGES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 3/10 cc syringe
1.4.2 1/2 cc syringe
1.4.3 1 cc syringe
1.4.4 Others
4.2 By Type, Global Insulin Syringes Market Size, 2019-2021
4.2.1 By Type, Global Insulin Syringes Market Size by Type, 2020-2021
4.2.2 By Type, Global Insulin Syringes Price, 2020-2021
5 IMPACT OF COVID-19 ON INSULIN SYRINGES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Homecare
5.5.3 Others
5.2 By Application, Global Insulin Syringes Market Size, 2019-2021
5.2.1 By Application, Global Insulin Syringes Market Size by Application, 2019-2021
5.2.2 By Application, Global Insulin Syringes Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Business Overview
7.1.2 Novo Nordisk Insulin Syringes Quarterly Production and Revenue, 2020
7.1.3 Novo Nordisk Insulin Syringes Product Introduction
7.1.4 Novo Nordisk Response to COVID-19 and Related Developments
7.2 Sanofi
7.2.1 Sanofi Business Overview
7.2.2 Sanofi Insulin Syringes Quarterly Production and Revenue, 2020
7.2.3 Sanofi Insulin Syringes Product Introduction
7.2.4 Sanofi Response to COVID-19 and Related Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Business Overview
7.3.2 Eli Lilly and Company Insulin Syringes Quarterly Production and Revenue, 2020
7.3.3 Eli Lilly and Company Insulin Syringes Product Introduction
7.3.4 Eli Lilly and Company Response to COVID-19 and Related Developments
7.4 Biocon Ltd
7.4.1 Biocon Ltd Business Overview
7.4.2 Biocon Ltd Insulin Syringes Quarterly Production and Revenue, 2020
7.4.3 Biocon Ltd Insulin Syringes Product Introduction
7.4.4 Biocon Ltd Response to COVID-19 and Related Developments
7.5 Ypsomed AG
7.5.1 Ypsomed AG Business Overview
7.5.2 Ypsomed AG Insulin Syringes Quarterly Production and Revenue, 2020
7.5.3 Ypsomed AG Insulin Syringes Product Introduction
7.5.4 Ypsomed AG Response to COVID-19 and Related Developments
7.6 Wockhardt Ltd
7.6.1 Wockhardt Ltd Business Overview
7.6.2 Wockhardt Ltd Insulin Syringes Quarterly Production and Revenue, 2020
7.6.3 Wockhardt Ltd Insulin Syringes Product Introduction
7.6.4 Wockhardt Ltd Response to COVID-19 and Related Developments
7.7 Medtronic Plc
7.7.1 Medtronic Plc Business Overview
7.7.2 Medtronic Plc Insulin Syringes Quarterly Production and Revenue, 2020
7.7.3 Medtronic Plc Insulin Syringes Product Introduction
7.7.4 Medtronic Plc Response to COVID-19 and Related Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Business Overview
7.8.2 Abbott Laboratories Insulin Syringes Quarterly Production and Revenue, 2020
7.8.3 Abbott Laboratories Insulin Syringes Product Introduction
7.8.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.9 Animas Corporation
7.9.1 Animas Corporation Business Overview
7.9.2 Animas Corporation Insulin Syringes Quarterly Production and Revenue, 2020
7.9.3 Animas Corporation Insulin Syringes Product Introduction
7.9.4 Animas Corporation Response to COVID-19 and Related Developments
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Business Overview
7.10.2 F. Hoffmann-La Roche Insulin Syringes Quarterly Production and Revenue, 2020
7.10.3 F. Hoffmann-La Roche Insulin Syringes Product Introduction
7.10.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
7.11 BD
7.11.1 BD Business Overview
7.11.2 BD Insulin Syringes Quarterly Production and Revenue, 2020
7.11.3 BD Insulin Syringes Product Introduction
7.11.4 BD Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Insulin Syringes Supply Chain Analysis
8.1.1 Insulin Syringes Supply Chain Analysis
8.1.2 Covid-19 Impact on Insulin Syringes Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Insulin Syringes Distribution Channels
8.2.2 Covid-19 Impact on Insulin Syringes Distribution Channels
8.2.3 Insulin Syringes Distributors
8.3 Insulin Syringes Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Insulin Syringes Assessment
Table 9. COVID-19 Impact: Insulin Syringes Market Trends
Table 10. COVID-19 Impact Global Insulin Syringes Market Size
Table 11. Global Insulin Syringes Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Insulin Syringes Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Insulin Syringes Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Insulin Syringes Market Growth Drivers
Table 17. Global Insulin Syringes Market Restraints
Table 18. Global Insulin Syringes Market Opportunities
Table 19. Global Insulin Syringes Market Challenges
Table 20. Key Manufacturers Insulin Syringes Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Insulin Syringes Market Size, 2019 (K Units) & (US$ Million)
Table 22. Insulin Syringes Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Insulin Syringes Manufacturing Plants
Table 24. Key Manufacturers Insulin Syringes Market Served
Table 25. Date of Key Manufacturers Enter into Insulin Syringes Market
Table 26. Key Manufacturers Insulin Syringes Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Insulin Syringes Market Size by Type, 2020, (US$ Million)
Table 29. Global Insulin Syringes Market Size by Type, 2020 (K Units)
Table 30. Global Insulin Syringes Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Insulin Syringes Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Insulin Syringes Market Size by Application, 2020-2021 (K Units)
Table 33. Global Insulin Syringes Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Insulin Syringes Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Insulin Syringes Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Insulin Syringes Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Insulin Syringes Market Size, 2019-2021 (K Units)
Table 38. US Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Insulin Syringes Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Insulin Syringes Market Size, 2019-2021 (K Units)
Table 43. Germany Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Insulin Syringes Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Insulin Syringes Market Size, 2019-2021 (K Units)
Table 50. China Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Novo Nordisk Business Overview
Table 58. Novo Nordisk Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Novo Nordisk Insulin Syringes Product
Table 60. Novo Nordisk Response to COVID-19 and Related Developments
Table 61. Sanofi Business Overview
Table 62. Sanofi Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Sanofi Insulin Syringes Product
Table 64. Sanofi Response to COVID-19 and Related Developments
Table 65. Eli Lilly and Company Business Overview
Table 66. Eli Lilly and Company Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eli Lilly and Company Insulin Syringes Product
Table 68. Eli Lilly and Company Response to COVID-19 and Related Developments
Table 69. Biocon Ltd Business Overview
Table 70. Biocon Ltd Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Biocon Ltd Insulin Syringes Product
Table 72. Biocon Ltd Response to COVID-19 and Related Developments
Table 73. Ypsomed AG Business Overview
Table 74. Ypsomed AG Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Ypsomed AG Insulin Syringes Product
Table 76. Ypsomed AG Response to COVID-19 and Related Developments
Table 77. Wockhardt Ltd Business Overview
Table 78. Wockhardt Ltd Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Wockhardt Ltd Insulin Syringes Product
Table 80. Wockhardt Ltd Response to COVID-19 and Related Developments
Table 81. Medtronic Plc Business Overview
Table 82. Medtronic Plc Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Medtronic Plc Insulin Syringes Product
Table 84. Medtronic Plc Response to COVID-19 and Related Developments
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Abbott Laboratories Insulin Syringes Product
Table 88. Abbott Laboratories Response to COVID-19 and Related Developments
Table 89. Animas Corporation Business Overview
Table 90. Animas Corporation Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Animas Corporation Insulin Syringes Product
Table 92. Animas Corporation Response to COVID-19 and Related Developments
Table 93. F. Hoffmann-La Roche Business Overview
Table 94. F. Hoffmann-La Roche Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. F. Hoffmann-La Roche Insulin Syringes Product
Table 96. F. Hoffmann-La Roche Response to COVID-19 and Related Developments
Table 97. BD Business Overview
Table 98. BD Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. BD Insulin Syringes Product
Table 100. BD Response to COVID-19 and Related Developments
Table 101. Insulin Syringes Distributors List
Table 102. Insulin Syringes Customers List
Table 103. Covid-19 Impact on Insulin Syringes Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Insulin Syringes Assessment
Table 9. COVID-19 Impact: Insulin Syringes Market Trends
Table 10. COVID-19 Impact Global Insulin Syringes Market Size
Table 11. Global Insulin Syringes Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Insulin Syringes Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Insulin Syringes Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Insulin Syringes Market Growth Drivers
Table 17. Global Insulin Syringes Market Restraints
Table 18. Global Insulin Syringes Market Opportunities
Table 19. Global Insulin Syringes Market Challenges
Table 20. Key Manufacturers Insulin Syringes Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Insulin Syringes Market Size, 2019 (K Units) & (US$ Million)
Table 22. Insulin Syringes Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Insulin Syringes Manufacturing Plants
Table 24. Key Manufacturers Insulin Syringes Market Served
Table 25. Date of Key Manufacturers Enter into Insulin Syringes Market
Table 26. Key Manufacturers Insulin Syringes Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Insulin Syringes Market Size by Type, 2020, (US$ Million)
Table 29. Global Insulin Syringes Market Size by Type, 2020 (K Units)
Table 30. Global Insulin Syringes Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Insulin Syringes Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Insulin Syringes Market Size by Application, 2020-2021 (K Units)
Table 33. Global Insulin Syringes Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Insulin Syringes Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Insulin Syringes Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Insulin Syringes Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Insulin Syringes Market Size, 2019-2021 (K Units)
Table 38. US Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Insulin Syringes Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Insulin Syringes Market Size, 2019-2021 (K Units)
Table 43. Germany Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Insulin Syringes Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Insulin Syringes Market Size, 2019-2021 (K Units)
Table 50. China Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Insulin Syringes Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Novo Nordisk Business Overview
Table 58. Novo Nordisk Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Novo Nordisk Insulin Syringes Product
Table 60. Novo Nordisk Response to COVID-19 and Related Developments
Table 61. Sanofi Business Overview
Table 62. Sanofi Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Sanofi Insulin Syringes Product
Table 64. Sanofi Response to COVID-19 and Related Developments
Table 65. Eli Lilly and Company Business Overview
Table 66. Eli Lilly and Company Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eli Lilly and Company Insulin Syringes Product
Table 68. Eli Lilly and Company Response to COVID-19 and Related Developments
Table 69. Biocon Ltd Business Overview
Table 70. Biocon Ltd Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Biocon Ltd Insulin Syringes Product
Table 72. Biocon Ltd Response to COVID-19 and Related Developments
Table 73. Ypsomed AG Business Overview
Table 74. Ypsomed AG Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Ypsomed AG Insulin Syringes Product
Table 76. Ypsomed AG Response to COVID-19 and Related Developments
Table 77. Wockhardt Ltd Business Overview
Table 78. Wockhardt Ltd Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Wockhardt Ltd Insulin Syringes Product
Table 80. Wockhardt Ltd Response to COVID-19 and Related Developments
Table 81. Medtronic Plc Business Overview
Table 82. Medtronic Plc Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Medtronic Plc Insulin Syringes Product
Table 84. Medtronic Plc Response to COVID-19 and Related Developments
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Abbott Laboratories Insulin Syringes Product
Table 88. Abbott Laboratories Response to COVID-19 and Related Developments
Table 89. Animas Corporation Business Overview
Table 90. Animas Corporation Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Animas Corporation Insulin Syringes Product
Table 92. Animas Corporation Response to COVID-19 and Related Developments
Table 93. F. Hoffmann-La Roche Business Overview
Table 94. F. Hoffmann-La Roche Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. F. Hoffmann-La Roche Insulin Syringes Product
Table 96. F. Hoffmann-La Roche Response to COVID-19 and Related Developments
Table 97. BD Business Overview
Table 98. BD Insulin Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. BD Insulin Syringes Product
Table 100. BD Response to COVID-19 and Related Developments
Table 101. Insulin Syringes Distributors List
Table 102. Insulin Syringes Customers List
Table 103. Covid-19 Impact on Insulin Syringes Customers
LIST OF FIGURES
Figure 1. Insulin Syringes Product Picture
Figure 2. Insulin Syringes Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Insulin Syringes Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Insulin Syringes Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Insulin Syringes Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Insulin Syringes Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Insulin Syringes Market Size Market Share, 2019-2021
Figure 1. Insulin Syringes Product Picture
Figure 2. Insulin Syringes Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Insulin Syringes Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Insulin Syringes Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Insulin Syringes Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Insulin Syringes Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Insulin Syringes Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Insulin Syringes Market Size Market Share, 2019-2021
